Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SMD Rise PCLBKK:SMD100-R 59 EV-to-Revenue is 0.55 as of Sep. 07, 2026, which is 47% below its 10-year median of 1.03. GuruFocus rates BKK:SMD100-R with a GF Score™ of 59/100 and a GF Value™ of ฿18.43. The stock has 9 warning signs investors should review. Among 122 Medical Distribution companies, SMD Rise PCL ranks better than 57.38% on this metric.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SMD Rise PCL's enterprise value is ฿602 Mil.
SMD Rise PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ฿1,091 Mil. Therefore, SMD Rise PCL's EV-to-Revenue for today is 0.55.
The historical rank and industry rank for SMD Rise PCL's EV-to-Revenue or its related term are showing as below:
BKK:SMD100-R'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.45 Med: 1.03 Max: 3.34
Current: 0.55
During the past 8 years, the highest EV-to-Revenue of SMD Rise PCL was 3.34. The lowest was 0.45. And the median was 1.03.
BKK:SMD100-R's EV-to-Revenue is ranked better than 57.38% of 122
companies
in the Medical Distribution industry
Industry Median: 0.605
vs BKK:SMD100-R: 0.55
As of today (2026-09-07), SMD Rise PCL's stock price is ฿5.85.
SMD Rise PCL's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ฿5.18. Therefore, SMD Rise PCL's PS Ratio for today is 1.13.
SMD Rise PCL's share price for today is ฿5.85.
SMD Rise PCL's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿5.18.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMD Rise PCL EV-to-Revenue Related Terms
SMD Rise PCL EV-to-Revenue Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, COR, CAH: EV-to-Revenue Comparison
For the Medical Distribution subindustry, SMD Rise PCL's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL EV-to-Revenue vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's EV-to-Revenue falls into.
SMD Rise PCL's current Enterprise Value is ฿602 Mil.
SMD Rise PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿1,091 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMD Rise PCL (BKK:SMD100-R) has a EV-to-Revenue of 0.55 as of Sep. 07, 2026. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on SMD Rise PCL and its competitors. This is 47% below median its historical median of 1.03. Over the past decade, SMD Rise PCL's EV-to-Revenue has ranged from 0.45 to 3.34. According to the industry distribution chart, SMD Rise PCL ranks #52 out of 122 companies in the Medical Distribution industry, placing it in the top 42.6%.
Is SMD Rise PCL's EV-to-Revenue too high?
SMD Rise PCL's current EV-to-Revenue of 0.55 is 47% below median its 10-year median of 1.03. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 3.34. The Medical Distribution industry median EV-to-Revenue is 0.61. SMD Rise PCL's value of 0.55 is 9.1% below this industry median. Based on the distribution chart, SMD Rise PCL ranks #52 out of 122 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's EV-to-Revenue compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #52 out of 122 companies for EV-to-Revenue. This puts SMD Rise PCL in the upper half of its industry. The industry median EV-to-Revenue is 0.61. SMD Rise PCL's value of 0.55 is 9.1% below this benchmark. Historically, SMD Rise PCL's own EV-to-Revenue has ranged from 0.45 to 3.34 over the past decade. While the company's 10-year median is 1.03 vs. the industry median of 0.61, SMD Rise PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-Revenue for a Medical Distribution company?
The median EV-to-Revenue among Medical Distribution companies is 0.61, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-Revenue significantly above this median, while those in the bottom quartile fall well below. However, EV-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current EV-to-Revenue of 0.55 is 9.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-Revenue mean?
A high EV-to-Revenue can signal that a stock is expensive relative to its fundamentals. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median EV-to-Revenue is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current EV-to-Revenue is 0.55, which is 47% below median its own 10-year median of 1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current EV-to-Revenue of 0.55. The stock's GF Value™ is ฿18.43, compared to a current price of ฿5.85 — trading 68.3% below its estimated fair value. The current EV-to-Revenue is 0.55, which is 47% below median its 10-year median of 1.03 and 9.1% below the Medical Distribution industry median of 0.61. SMD Rise PCL's overall GF Score™ is 59/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-Revenue calculated?
EV-to-Revenue is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current EV-to-Revenue is 0.55 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 68.3% below its estimated GF Value™ of ฿18.43.
Key valuation signals for BKK:SMD100-R:
EV-to-Revenue: 0.55 (47% below median its 10-year median of 1.03)
GF Value™: ฿18.43 vs. price of ฿5.85 (68.3% below fair value)
Industry Position: 9.1% below the Medical Distribution median (#52 of 122)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
EV-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
